Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an announcement.
ResMed Inc reported a change in beneficial ownership as Director John Hernandez executed transactions involving the company’s common stock. On August 18, 2025, Hernandez acquired 2,575 shares through stock options at a price of $148.90 and subsequently sold the same amount at a weighted average price of $287.10, reflecting strategic financial management. These transactions indicate active engagement by the company’s leadership in managing their equity positions, potentially impacting investor perceptions and market dynamics.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$51.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders, respiratory care, and connected health solutions. The company is a key player in providing innovative solutions for patients with sleep apnea and other chronic respiratory conditions.
Average Trading Volume: 890,958
Technical Sentiment Signal: Buy
Current Market Cap: A$64.61B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.